Results 91 to 100 of about 16,509 (232)

A better effect of cilostazol for reducing in-stent restenosis after femoropopliteal artery stent placement in comparison with ticlopidine

Medical Devices: Evidence and Research, 2011
Ichiro Ikushima1, Kazuchika Yonenaga1, Hironao Iwakiri2, Hideki Nagoshi2, Haruhito Kumagai2, Yasuyuki Yamashita31Department of Radiology, 2Department of Cardiology, Miyakonojo Medical Association Hospital, Miyakonojo, Japan; 3Department of Diagnostic ...
Ikushima I, Yonenaga K, Iwakiri H, Nagoshi H, Kumagai H, Yamashita Y   +5 more
doaj  

A terapêutica médica da angina de peito.

Acta Médica Portuguesa, 1997
The angina pectoris crisis should be treated with nitroglycerin S.L.. In our days as in the 19th century, the non pharmacological therapeutic approach for angina pectoris (per se and to improve the free interval between crises) is still the same.
J G Clara
doaj   +1 more source

Late coronary occlusion after intracoronary brachytherapy [PDF]

, 1999
BACKGROUND: Intracoronary brachytherapy appears to be a promising technology to prevent restenosis. Presently, limited data are available regarding the late safety of this therapeutic modality.
Cervinka, P., Coen, V.L.M.A. (Veronique), Costa, M.A. (Marco), Giessen, W.J. (Wim) van der, Kay, I.P. (Ian Patrick), Levendag, P.C. (Peter), Ligthart, J.M.R. (Jürgen), Sabaté, M. (Manel), Serrano, P. (Pedro), Serruys, P.W.J.C. (Patrick)   +9 more
core  

S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty [PDF]

, 2002
Background: The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period.
Clifton, A., Kaposzta, Z., Markus, H.S., Martin, J.F., Molloy, J.   +4 more
core   +1 more source

Clopidogrel-Induced Neutropenia after Coronary Stenting: Is Cilostazol a Good Alternative?

International Journal of Vascular Medicine, 2011
Dual antiplatelet therapy with aspirin plus thienopyridines has become the standard treatment of patients undergoing coronary stenting. Clopidogrel has mostly replaced the use of ticlopidine due to its more favourable adverse event profile. However, also
Massimo Montalto, Italo Porto, Antonella Gallo, Claudia Camaioni, Roberta Della Bona, Antonio Grieco, Filippo Crea, Raffaele Landolfi   +7 more
doaj   +1 more source

Silence of the limbs: pharmacological symptomatic treatment of intermittent claudication [PDF]

, 2010
Several oral "vasoactive" drugs claim to increase walking capacity in patients with intermittent claudication (IC). Naftidrofuryl, cilostazol, buflomedil, and pentoxifylline are the most studied molecules.
De Backer, Gui, De Backer, Tine, De Buyzere, Marc, Van Bortel, Lucas, Vander Stichele, Robert   +4 more
core   +1 more source

Aortic thrombus in a patient with myeloproliferative thrombocytosis, successfully treated by pharmaceutical therapy: a case report

Journal of Medical Case Reports, 2010
Introduction Thrombosis in myeloproliferative thrombocytosis occurs usually in the microvessels and medium-sized arteries and veins and only rarely in the aorta. Aortic thrombosis is usually treated with thrombectomy.
Imai Norikazu, Nishimaki Haruaki, Yamamoto Hidesuke, Nitta Masakazu, Daimaru Osami   +4 more
doaj   +1 more source

The FDA Has Ended Required Blood Monitoring for Clozapine Use—Will This Impact the Management of Parkinson's Disease Psychosis?

Movement Disorders, Volume 40, Issue 9, Page 1821-1825, September 2025.
Daniel Weintraub, Izabelle Schoen
wiley   +1 more source

Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome [PDF]

, 2017
Aims To investigate the efficacy and outcome of emergency percutaneous coronary interventions (PCI) in patients with stent thrombosis. Methods and results Between 1995 and 2003, 6058 patients underwent bare-metal stent implantation, of which 95 (1.6 ...
Eberli, Franz R., Hess, Otto M., Locher, Stefan, Meier, Bernhard, Remondino, Andrea, Rey, Christoph, Seiler, Christian, Togni, Mario, Tüller, David, Wenaweser, Peter, Windecker, Stephan   +10 more
core  

Analysis of the structure of consumption of antiplatelet drugs in the Russian pharmaceutical market: 2014-2016

Качественная клиническая практика, 2018
This article analyzes the volume of the Russian pharmaceutical market of antiplatelet drugs in the period 2014-2016. 80% of patients take clopidogrel generics, giving preference to Zilt®.
S. K. Zyryanov, E. V. Dumchenko
doaj